The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis

Published:2013-04 Issue:S1 Volume:14 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Cottin Vincent

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/1465-9921-14-S1-S5.pdf

Reference31 articles.

1. Raghu G, Weycker D, Edelsberg J, et al: Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006, 174: 810-816. 10.1164/rccm.200602-163OC.

2. Hodgson U, Laitinen T, Tukiainen P: Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002, 57: 338-342. 10.1136/thorax.57.4.338.

3. Orphanet: Orphanet Report Series. Rare Diseases collection. Prevalence of rare diseases: Bibliographic data. 2011, [ http://www.orphanet.net ]Number 1

4. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D: Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev. 2012, 21 (126): 355-61. 10.1183/09059180.00002512.

5. Collard HR, King TE, Bartelson BB, et al: Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003, 168 (5): 538-542. 10.1164/rccm.200211-1311OC.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal and Skin Safety Evaluation of Pirfenidone Versus Nintedanib: An Analysis of Real-World Pharmacovigilance and Randomized Controlled Trials;2024

2. Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects in a bleomycin-induced in vitro fibrosis model;2022-08-16

3. The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β;Cancer Biology & Therapy;2022-02-07

4. The safety and tolerability of pirfenidone in Indian patients with idiopathic pulmonary fibrosis;Current Medical Issues;2022

5. On-demand responsive nanoplatform mediated targeting of CAFs and down-regulating mtROS-PYK2 signaling for antitumor metastasis;Biomaterials Science;2021